가금류 진단 시장 기회와 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Poultry Diagnostics Market, valued at USD 702.5 million in 2023, is anticipated to grow at a CAGR of 10.5% from 2024 to 2032. Poultry diagnostics are essential tools and methods used to detect and manage diseases in birds raised for meat and eggs. Utilizing techniques like molecular diagnostics and serological tests, these tools help identify pathogens and monitor flock health, addressing diseases such as avian influenza and salmonellosis. Effective diagnostics play a crucial role in disease control, biosecurity, and the economic stability of poultry farming. A primary driver of this market growth is the increasing awareness of the impact of poultry diseases on food safety and public health.

Stricter regulations worldwide aim to enhance poultry health standards, resulting in the expanded use of diagnostic tools for early disease identification and prevention. Such tools are vital for detecting diseases like avian influenza, Newcastle disease, and Salmonella at early stages, allowing timely interventions to prevent outbreaks. The market is divided into components, primarily products and services. The product segment, which held a 60.4% market share in 2023, is further categorized into kits & reagents and equipment & instruments.

Products such as diagnostic kits and reagents are popular for their cost-effectiveness and accessibility, allowing farmers to monitor flock health with minimal training. Rapid test kits, providing quick results, are particularly beneficial, enabling farmers to manage flock health in real-time and prevent disease escalation. In terms of technology, the market is segmented into PCR tests, ELISA tests, and others. ELISA tests, valued at USD 403.2 million in 2023, dominate the segment due to their high sensitivity and specificity in detecting a wide array of poultry pathogens.

ELISA's rapid results and recent technological advancements make it a preferred option among poultry producers seeking reliable diagnostics. Disease-wise, the market includes avian influenza, Newcastle disease, avian salmonellosis, and others. The avian influenza segment is projected to grow at a rate of 10.8% over the forecast period. Due to its contagious nature and impact on both poultry and human populations, early detection and control of avian influenza have become critical, driving investment in diagnostics.

End users of poultry diagnostics include veterinary hospitals & clinics, poultry farms, and diagnostic laboratories. In 2023, the veterinary hospitals & clinics segment was valued at USD 323.8 million, driven by the growing prevalence of poultry diseases and the demand for specialized diagnostic services that ensure accurate disease detection. In the U.S., valued at USD 257.8 million in 2023, the poultry diagnostics market is expected to reach USD 616.8 million by 2032

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing poultry consumption
    • 3.2.1.2 Growing awareness of poultry health
    • 3.2.1.3 Rising incidence of zoonotic diseases
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Limited access to advanced technologies in developing regions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Pricing analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Products
  • 5.2.1 Kits & reagents
  • 5.2.2 Equipment & instruments
• 5.3 Services
  • 5.3.1 Clinical chemistry
  • 5.3.2 Molecular diagnostics
  • 5.3.3 Serology
  • 5.3.4 Bacteriology
  • 5.3.5 Virology
  • 5.3.6 Parasitology
  • 5.3.7 Other services

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 ELISA tests
• 6.3 PCR test
• 6.4 Other technologies

Chapter 7 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Avian influenza
• 7.3 Avian salmonellosis
• 7.4 Newcastle disease
• 7.5 Avian mycoplasmosis
• 7.6 Infectious bronchitis
• 7.7 Infectious bursal disease
• 7.8 Avian pasteurellosis
• 7.9 Avian encephalomyelitis
• 7.10 Avian reovirus
• 7.11 Chicken anemia
• 7.12 Other diseases

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals & clinics
• 8.3 Poultry farms
• 8.4 Diagnostic laboratories

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Affinitech
• 10.2 Agrobiotek Internacional
• 10.3 Agrolabo
• 10.4 Antech Diagnostics
• 10.5 BIOMERIEUX
• 10.6 Boehringer Ingelheim
• 10.7 Embark Veterinary
• 10.8 FUJIFILM Corporation
• 10.9 GD Animal Health
• 10.10 IDEXX Laboratories
• 10.11 IDvet
• 10.12 Innovative Diagnostics
• 10.13 Megacor Diagnostik
• 10.14 Thermo Fisher Scientific
• 10.15 Zoetis